NKTX PEER ANALYSIS

Nkarta Inc — metric-by-metric comparison with peers and the industry median

NKTXNkarta Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

NKTXIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	NKTX	MSB	RTALB	TLX	Ind. Median
P/E	—	—	4.89	—	17.81
P/B	0.86	—	0.61●	6.56	3.49
EV/EBITDA	—	—	74.61●	123.31	14.92
P/S	—	31.91	6.67	3.34●	10.89

Financial Health
Metric	NKTX	MSB	RTALB	TLX	Ind. Median
Current Ratio	12.96●	—	1.21	1.43	5.90
Debt/Equity	26.2%	—	1.2%●	112.3%	10.9%
NetDebt/EBITDA	1.71	—	0.90●	13.13	1.15

Profitability
Metric	NKTX	MSB	RTALB	TLX	Ind. Median
Net Margin	—	-115.3%	136.3%●	-0.9%	-125.7%
ROE	-30.1%	-11.3%	15.1%●	-1.8%	-47.5%
ROA	-23.7%	-8.6%	13.1%●	-0.7%	-35.8%
EBITDA Margin	—	-76.6%	9.0%●	3.0%	-105.8%

Growth + Dividend
Metric	NKTX	MSB	RTALB	TLX	Ind. Median
Rev. Growth	-100.0%	410.4%●	24.0%	56.3%	5.1%
NI Growth	—	—	134.0%	—	12.1%
Div. Yield	—	0.0%●	0.0%●	—	0.2%
Payout	—	0.0%	0.0%	—	0.0%

Valuation
Metric	NKTX	KPTI	RNA	AVXL	SGMT	IMRX	Ind. Median
P/E	—	—	—	—	—	—	17.81
P/B	0.86	-0.90●	0.95	1.87	2.46	0.00	3.49
EV/EBITDA	—	—	—	—	—	—	14.92
P/S	—	1.57●	6.04	—	—	—	10.89

Financial Health
Metric	NKTX	KPTI	RNA	AVXL	SGMT	IMRX	Ind. Median
Current Ratio	12.96	1.08	13.04	20.87	20.34	32.45●	5.90
Debt/Equity	26.2%	-86.9%●	1.1%	—	0.0%	1.8%	10.9%
NetDebt/EBITDA	1.71	-0.95	0.65	—	2.27	-60.72●	1.15

Profitability
Metric	NKTX	KPTI	RNA	AVXL	SGMT	IMRX	Ind. Median
Net Margin	—	-129.0%●	-1,076.9%	—	—	—	-125.7%
ROE	-30.1%	—	-50.7%	-33.6%	-36.0%	-0.1%●	-47.5%
ROA	-23.7%	-150.5%	-45.3%	-31.1%	-34.3%	-0.1%●	-35.8%
EBITDA Margin	—	-97.9%●	-1,108.5%	—	—	—	-105.8%

Growth + Dividend
Metric	NKTX	KPTI	RNA	AVXL	SGMT	IMRX	Ind. Median
Rev. Growth	-100.0%	6.3%	312.4%●	—	—	-100.0%	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on NKTX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.